Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Truepill

Explore full profile

A software-powered pharmacy of the future, serving healthcare brands worldwide delivering world-class patient experiences through API-connected healthcare infrastructure

Hayward, United StatesFounded 2016Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2024
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Truepill and the history behind them.

About Truepill

Truepill is a healthcare infrastructure company that aims to make healthcare more accessible and affordable. Founded in 2016, Truepill serves a wide range of clients, including healthcare providers, insurers, and direct-to-consumer health brands. The company operates primarily in the U.S. healthcare market, offering a suite of services designed to modernize and streamline healthcare delivery.

Truepill's business model revolves around providing a comprehensive healthcare platform that includes pharmacy services, telehealth, and diagnostics. The company operates accredited pharmacies that can ship prescription (Rx) and over-the-counter (OTC) medications to all 50 states. They support both insurance-covered and cash payments, making it easier for patients to get the medications they need.

In addition to pharmacy services, Truepill offers telehealth solutions, enabling licensed U.S. physicians to consult with patients via asynchronous (not in real-time), video, and in-person visits. This service is available 24/7, covering a variety of specialties such as urgent care, primary care, women's health, men's health, weight loss, diabetes management, and chronic condition management.

Truepill also provides diagnostic services, offering over 3,000 tests through at-home kits, mobile phlebotomy (blood drawing), and an in-person lab testing network. These services are white-labeled, meaning they can be branded under the names of Truepill's partner organizations.

The company makes money by charging fees for its pharmacy, telehealth, and diagnostic services. These fees can come from healthcare providers, insurers, or directly from consumers. By integrating these services into a single platform, Truepill aims to create a seamless healthcare experience for patients and providers alike.

In summary, Truepill is transforming the healthcare landscape by providing a modern, integrated platform that simplifies access to medications, telehealth consultations, and diagnostic tests.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2016
Headquarters
Hayward, United States
Employees
331
Open positions
None listed
Dealroom signal
64.0/100
Industry
Health
Sub-industry
Pharmaceutical, Health Platform
Sector
Biotech & Life Sciences, Pharmacy, Biotechnology, Tech for Patients, From Unicorn to Zebra (But No $1B Exit), Biotech and Pharma, Hard Tech, YC S17, DT and LS, science-based
Business model
SaaS
Client focus
b2c
Investment activity
1 company, latest Jul 2020
Capital deployed
$9M
Preferred round
SEED

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Aug 2024 $525M $525M LetsGetChecked ↗
SERIES DOther financing Oct 2021 $142M $1.6B Initialized Capital · Transpose Platform —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Truepill website traffic

Latest recorded traffic for Truepill is 2.5K monthly website visits, up 47.1% over the last three months. Truepill's team declined 27.1% over the past year.

Latest monthly visits2.5K 3-month web change+47.1% 1-year team growth-27.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A5 investors entered at this stage

Series B and later3 investors entered at this stage

  • Oak HC/FT
  • Trusted Insight
  • Transpose Platform

Other known investors1 additional known investor

  • LetsGetChecked
Team profiled 34 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States95.2%
🇬🇧 United Kingdom3.2%
🇺🇾 Uruguay1.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Truepill on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Truepill’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.